TRAFALGAR INTERNATIONAL, INC.

GCAN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015
Operating Activities
Net Income $-807.2K $-103.0K $-3.2K
Depreciation & Amortization
Depreciation
Amortization
Stock-Based Compensation $532.5K
Net Cash from Operating Activities $-36.3K
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $37.3K
Net Change in Cash $993
Free Cash Flow
← Newer Page 2 of 2 Older →